EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 157 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,426,254 | -43.1% | 280,688 | -29.9% | 0.00% | -50.0% |
Q2 2023 | $7,785,763 | -40.1% | 400,499 | -12.6% | 0.00% | -50.0% |
Q1 2023 | $13,001,994 | +127133.5% | 458,312 | +31.1% | 0.00% | +33.3% |
Q4 2022 | $10,219 | -99.9% | 349,606 | -1.7% | 0.00% | -25.0% |
Q3 2022 | $9,401,000 | -33.4% | 355,759 | +12.0% | 0.00% | -20.0% |
Q2 2022 | $14,114,000 | -6.4% | 317,676 | +4.2% | 0.01% | 0.0% |
Q1 2022 | $15,084,000 | +2.2% | 304,784 | +5.2% | 0.01% | +25.0% |
Q4 2021 | $14,753,000 | -5.7% | 289,729 | +3.2% | 0.00% | -20.0% |
Q3 2021 | $15,653,000 | +21.4% | 280,620 | -6.8% | 0.01% | +25.0% |
Q2 2021 | $12,890,000 | -5.8% | 301,177 | -8.2% | 0.00% | -20.0% |
Q1 2021 | $13,686,000 | -4.3% | 327,907 | +6.8% | 0.01% | 0.0% |
Q4 2020 | $14,297,000 | +12.8% | 307,010 | +2.9% | 0.01% | 0.0% |
Q3 2020 | $12,671,000 | -10.4% | 298,292 | +1.2% | 0.01% | -16.7% |
Q2 2020 | $14,142,000 | +3.8% | 294,740 | -0.5% | 0.01% | -14.3% |
Q1 2020 | $13,621,000 | -21.6% | 296,119 | +2.4% | 0.01% | +16.7% |
Q4 2019 | $17,378,000 | +12.4% | 289,244 | +5.9% | 0.01% | 0.0% |
Q3 2019 | $15,455,000 | +11.9% | 273,210 | +10.1% | 0.01% | +20.0% |
Q2 2019 | $13,811,000 | +107.8% | 248,048 | +88.5% | 0.01% | +66.7% |
Q1 2019 | $6,645,000 | +25.3% | 131,605 | 0.0% | 0.00% | +50.0% |
Q4 2018 | $5,302,000 | -8.1% | 131,605 | +58.1% | 0.00% | 0.0% |
Q3 2018 | $5,771,000 | +44.3% | 83,246 | +57.6% | 0.00% | 0.0% |
Q2 2018 | $3,998,000 | +154.0% | 52,836 | +76.9% | 0.00% | +100.0% |
Q1 2018 | $1,574,000 | -3.0% | 29,876 | -1.6% | 0.00% | 0.0% |
Q4 2017 | $1,622,000 | -16.8% | 30,372 | -7.1% | 0.00% | 0.0% |
Q3 2017 | $1,949,000 | -23.5% | 32,686 | +1.2% | 0.00% | 0.0% |
Q2 2017 | $2,548,000 | +313.0% | 32,298 | +334.3% | 0.00% | – |
Q1 2017 | $617,000 | +4.6% | 7,437 | 0.0% | 0.00% | – |
Q4 2016 | $590,000 | – | 7,437 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |